Immunocore Holdings plc (IMCR) earnings date

Nasdaq · Small cap · EDGAR filings

Email me when this date changes · free account, one click to stop

How this company behaves

Announces its report date Not enough announcements on file yet to say
Reports after the quarter ends 37 days, typically, give or take 9 (last 8 releases)

Last 8 releases

PeriodReleasedTimingDays after period endFiling
Q3 FY2026Fri, Nov 6, 2026before open 37 8-K
Q2 FY2026Thu, Aug 6, 2026before open 37 8-K
Q1 FY2026Wed, May 6, 2026before open 36 8-K
Q4 FY2025Wed, Feb 25, 2026before open 56 8-K
Q3 FY2025Thu, Nov 6, 2025before open 37 8-K
Q2 FY2025Thu, Aug 7, 2025before open 38 8-K
Q1 FY2025Wed, May 7, 2025before open 37 8-K
Q4 FY2024Wed, Feb 26, 2025before open 57 8-K

What they guided beta

Q3 FY2026 "Document Immunocore reports third quarter financial results and provides a business update KIMMTRAK® (tebentafusp-tebn) net revenues of $102.2 million in Q3 2026 and net revenues of $324.8 million for the first nine months of 2026, representing 10% year-over-year growth year to date Phase 3 TEBE-AM trial for previously treated advanced cutaneous melanoma completed target enrollment of 540 patients – Topline overall survival data expected second quarter of 2027 Promising Phase 1 data with KIMMTRAK plus brenetafusp to be presented as a late-breaking oral at SITC - Randomized Phase 2/3 DUET-UVEAL" exhibit
Q3 FY2026 "With TEBE-AM fully enrolled and data expected in the second quarter of 2027, we are advancing our mission to bring this therapy to even more patients,” said Bahija Jallal, CEO of Immunocore." exhibit
Q3 FY2026 "The Company expects to pay, in the fourth quarter of 2026, approximately $120 million in sales-related rebate accruals." exhibit
Q3 FY2026 "The trial is event-driven and topline overall survival data is expected in the second quarter of 2027." exhibit
Q2 FY2026 "The Company expects to pay, in the second half of 2026, approximately $120 million in sales-related rebate accruals." exhibit
Q2 FY2026 "The Company expects to present Phase 1/2 data from both trials in the second half of 2026." exhibit

Get this as JSON

curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/IMCR
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/IMCR

Put this date on your page

A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.

Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.

IMCR earnings date badge

HTML

<a href="https://veritasdata.dev/company/IMCR/"><img src="https://veritasdata.dev/embed/IMCR.svg" alt="IMCR earnings date" width="240" height="56"></a>

Markdown

[![IMCR earnings date](https://veritasdata.dev/embed/IMCR.svg)](https://veritasdata.dev/company/IMCR/)

Script

<script async src="https://veritasdata.dev/embed/IMCR.js"></script>

Get a free key: 100 calls, every company

Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.

curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/IMCR"

Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.